XML 62 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
May 31, 2014
May 31, 2013
May 31, 2012
Income Statement [Abstract]      
Net sales $ 354,425us-gaap_SalesRevenueNet $ 341,916us-gaap_SalesRevenueNet $ 221,917us-gaap_SalesRevenueNet
Cost of sales 174,757us-gaap_CostOfGoodsSold 173,402us-gaap_CostOfGoodsSold 96,608us-gaap_CostOfGoodsSold
Gross profit 179,668us-gaap_GrossProfit 168,514us-gaap_GrossProfit 125,309us-gaap_GrossProfit
Operating expenses      
Research and development 27,486us-gaap_ResearchAndDevelopmentExpense 26,319us-gaap_ResearchAndDevelopmentExpense 20,511us-gaap_ResearchAndDevelopmentExpense
Sales and marketing 83,200us-gaap_SellingAndMarketingExpense 76,121us-gaap_SellingAndMarketingExpense 64,505us-gaap_SellingAndMarketingExpense
General and administrative 26,639us-gaap_GeneralAndAdministrativeExpense 26,186us-gaap_GeneralAndAdministrativeExpense 19,033us-gaap_GeneralAndAdministrativeExpense
Amortization of intangibles 16,622us-gaap_AmortizationOfIntangibleAssets 16,617us-gaap_AmortizationOfIntangibleAssets 9,309us-gaap_AmortizationOfIntangibleAssets
Change in fair value of contingent consideration (1,808)ango_ChangeInFairValueOfContingentConsideration 1,583ango_ChangeInFairValueOfContingentConsideration 0ango_ChangeInFairValueOfContingentConsideration
Acquisition, restructuring and other items, net 10,760ango_AcquisitionRestructuringAndOtherItemsNet 13,800ango_AcquisitionRestructuringAndOtherItemsNet 15,859ango_AcquisitionRestructuringAndOtherItemsNet
Medical device excise tax 3,829ango_MedicalDeviceExciseTax 1,600ango_MedicalDeviceExciseTax 0ango_MedicalDeviceExciseTax
Total operating expenses 166,728us-gaap_OperatingExpenses 162,226us-gaap_OperatingExpenses 129,217us-gaap_OperatingExpenses
Operating income (loss) 12,940us-gaap_OperatingIncomeLoss 6,288us-gaap_OperatingIncomeLoss (3,908)us-gaap_OperatingIncomeLoss
Other (expenses) income      
Interest income 0us-gaap_InvestmentIncomeInterest 103us-gaap_InvestmentIncomeInterest 1,090us-gaap_InvestmentIncomeInterest
Interest expense (3,656)us-gaap_InterestExpense (5,271)us-gaap_InterestExpense (508)us-gaap_InterestExpense
Other expense (3,544)us-gaap_OtherNonoperatingExpense (2,707)us-gaap_OtherNonoperatingExpense (2,096)us-gaap_OtherNonoperatingExpense
Total other expenses, net (7,200)us-gaap_OtherNonoperatingIncomeExpense (7,875)us-gaap_OtherNonoperatingIncomeExpense (1,514)us-gaap_OtherNonoperatingIncomeExpense
Income (loss) before income tax expense (benefit) 5,740us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments (1,587)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments (5,422)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense (benefit) 3,074us-gaap_IncomeTaxExpenseBenefit (376)us-gaap_IncomeTaxExpenseBenefit (239)us-gaap_IncomeTaxExpenseBenefit
Net income (loss) $ 2,666us-gaap_NetIncomeLoss $ (1,211)us-gaap_NetIncomeLoss $ (5,183)us-gaap_NetIncomeLoss
Earnings per share      
Basic (usd per share) $ 0.08us-gaap_EarningsPerShareBasic $ (0.03)us-gaap_EarningsPerShareBasic $ (0.20)us-gaap_EarningsPerShareBasic
Diluted (usd per share) $ 0.08us-gaap_EarningsPerShareDiluted $ (0.03)us-gaap_EarningsPerShareDiluted $ (0.20)us-gaap_EarningsPerShareDiluted
Basic weighted average shares outstanding (in shares) 35,135,689us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 34,817,279us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 25,382,293us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Diluted weighted average shares outstanding (in shares) 35,439,850us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 34,817,279us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 25,382,293us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding